| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CUTTING EDGE |
Transplant Research Laboratory and Endocrine-Diabetes Center, St. Luke’s Medical Center, and Department of Laboratory Medicine and Pathology, University of Wisconsin Medical School, Milwaukee Clinical Campus, Milwaukee, WI 53215
We have recently identified a novel transcript of the CTLA-4 gene that may represent a native soluble form of CTLA-4 (sCTLA-4). To determine whether sCTLA-4 was expressed in humans, we applied a sensitive enzyme immunoassay on serum from patients with autoimmune thyroid disease (ATD). Eleven of 20 patients with ATD had circulating levels of sCTLA-4 ranging from 28 to 78 ng/ml, whereas only 1 of 30 apparently healthy volunteers had a level greater than 4 ng/ml. sCTLA-4 immunoreactivity was inhibited by its binding to B7.1, suggesting that sCTLA-4 is a functional receptor. Immunoprecipitation analysis of serum from patients with ATD revealed a polypeptide consistent with the predicted size of sCTLA-4. We conclude that a native soluble form of CTLA-4 is derived from an alternate transcript of the CTLA-4 gene, and its level in plasma is elevated among a population of patients with ATD.
This article has been cited by other articles:
|
|
 |
|
  J. Daroszewski, E. Pawlak, L. Karabon, I. Frydecka, A. Jonkisz, M. Slowik, and M. Bolanowski Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms Eur. J. Endocrinol., November 1, 2009; 161(5): 787 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Simone, R. Brizzolara, A. Chiappori, F. Milintenda-Floriani, C. Natale, L. Greco, M. Schiavo, M. Bagnasco, G. Pesce, and D. Saverino A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury Int. Immunol., September 1, 2009; 21(9): 1037 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. K. Decker, D. Xing, S. Li, S. N. Robinson, H. Yang, D. Steiner, K. V. Komanduri, and E. J. Shpall Th-1 polarization is regulated by dendritic-cell comparison of MHC class I and class II antigens Blood, April 30, 2009; 113(18): 4213 - 4223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. H. Garin, L. N. Diaz, W. Mu, C. Wasserfall, C. Araya, M. Segal, and R. J. Johnson Urinary CD80 Excretion Increases in Idiopathic Minimal-Change Disease J. Am. Soc. Nephrol., February 1, 2009; 20(2): 260 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Perez-Garcia, R. De la Camara, J. Roman-Gomez, A. Jimenez-Velasco, M. Encuentra, J. B. Nieto, J. de la Rubia, A. Urbano-Ispizua, S. Brunet, A. Iriondo, et al. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood, July 1, 2007; 110(1): 461 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O Tapirdamaz, V Pravica, H J Metselaar, B Hansen, L Moons, J B J van Meurs, I V Hutchinson, J Shaw, K Agarwal, D H Adams, et al. Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation Gut, June 1, 2006; 55(6): 863 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Geng, G.-M. Zhang, D. Li, H. Zhang, Y. Yuan, H.-G. Zhu, H. Xiao, L.-F. Han, and Z.-H. Feng Soluble Form of T Cell Ig Mucin 3 Is an Inhibitory Molecule in T Cell-Mediated Immune Response J. Immunol., February 1, 2006; 176(3): 1411 - 1420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Homann, W. Dummer, T. Wolfe, E. Rodrigo, A. N. Theofilopoulos, M. B. A. Oldstone, and M. G. von Herrath Lack of Intrinsic CTLA-4 Expression Has Minimal Effect on Regulation of Antiviral T-Cell Immunity J. Virol., January 1, 2006; 80(1): 270 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Wong, L. C. W. Lit, L. S. Tam, E. K. Li, and C. W. K. Lam Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus Rheumatology, August 1, 2005; 44(8): 989 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Simmonds and S. C. L. Gough Genetic insights into disease mechanisms of autoimmunity Br. Med. Bull., February 8, 2005; 71(1): 93 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Riley and C. H. June The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation Blood, January 1, 2005; 105(1): 13 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sato, M. Fujimoto, M. Hasegawa, K. Komura, K. Yanaba, I. Hayakawa, T. Matsushita, and K. Takehara Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis Rheumatology, October 1, 2004; 43(10): 1261 - 1266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Wicker, G. Chamberlain, K. Hunter, D. Rainbow, S. Howlett, P. Tiffen, J. Clark, A. Gonzalez-Munoz, A. M. Cumiskey, R. L. Rosa, et al. Fine Mapping, Gene Content, Comparative Sequencing, and Expression Analyses Support Ctla4 and Nramp1 as Candidates for Idd5.1 and Idd5.2 in the Nonobese Diabetic Mouse J. Immunol., July 1, 2004; 173(1): 164 - 173. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
